SCHEMBL8286151

SCHEMBL8286151

CCC(O)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.36
CYP2C9 P11712 1/20 0.34
FPR1 P21462 1/20 0.34
CSF1R P07333 1/20 0.34
MAT2A P31153 4/20 0.34
CDK4 P11802 2/20 0.33
CCND1 P24385 2/20 0.33
CCND2 P30279 2/20 0.33
CCND3 P30281 2/20 0.33
PDE11A Q9HCR9 1/20 0.33
GAA P10253 3/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 2/20 0.33
EGFR P00533 1/20 0.32
BTK Q06187 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
KDM4E B2RXH2 2/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286154 0.86 GSK3B (0.42) GSK3BCYP2C9MAT2ACDK4CCND1
SCHEMBL8287920 0.82 CSF1R (0.37) GSK3BCYP2C9FPR1CSF1RMAT2A
SCHEMBL8286150 0.81 GSK3B (0.39) GSK3BCSF1RMAT2ACDK4CCND1
SCHEMBL8286502 0.80 MAPT (0.33) GSK3BCYP2C9CDK4CCND1CCND2
SCHEMBL5872050 0.80 GAA (0.44) GSK3BCYP2C9MAT2ACDK4CCND1
SCHEMBL8285261 0.80 GSK3B (0.38) GSK3BCSF1RMAT2ACDK4CCND1
SCHEMBL8287486 0.80 LMNA (0.37) GSK3BCSF1RMAT2ACDK4CCND1
SCHEMBL8286516 0.79 LMNA (0.39) MAT2AGAAHPGDKDM4EMAPT
SCHEMBL8287617 0.79 GSK3B (0.37) GSK3BCSF1RMAT2ACDK4CCND1
SCHEMBL8286162 0.79 GSK3B (0.37) GSK3BCSF1RMAT2ACDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed